Key facts
- This page summarizes Marjorie Shreiber Roshkoff's Form 4 filing for J&J SNACK FOODS CORP (JJSF).
- 6 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2024, 16:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023. This is a weighted average price for the shares reported. These shares were sold in multiple transactions at prices ranging from $158.46 and $158.83. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 of this Form.
Footnote F2
Consists of 3,498,511 shares of common stock held in The 2021 Irrevocable Trust for Mr. Gerald B. Shreiber, for which Ms. Roshkoff is trustee, 217,642 shares held in an Intentionally Defective Grantor Trust for Ms. Roshkoff and her siblings, for which Ms. Roshkoff is Trustee, and 18,756 shares held for the benefit of Ms. Roshkoff's children in trust or custodian accounts. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16, or any other purpose.
Footnote F3
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023. This is a weighted average price for the shares reported. These shares were sold in multiple transactions at prices ranging from $159.48 and $159.95. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 of this Form.
Footnote F4
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023. This is a weighted average price for the shares reported. These shares were sold in multiple transactions at prices ranging from $160.51 and $161.45. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 of this Form.
Footnote F5
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023. This is a weighted average price for the shares reported. These shares were sold in multiple transactions at prices ranging from $161.58.and $162.22. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 of this Form.
Footnote F6
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023. This is a weighted average price for the shares reported. These shares were sold in multiple transactions at prices ranging from $164.06 and $164.10. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 6 of this Form.
Footnote F7
Shares were sold pursuant to a 10b5-1 Trading Plan established on May 10, 2023.